H.R. 9756House119th Congress (2025-2027)In Committee

MAT Act of 2026

AI-Generated Summary

Updated July 21, 2026 at 4:41 AM UTC

The Maternal Access to Treatment (MAT) Act of 2026 requires the Federal Bureau of Prisons to provide opioid addiction medication‑assisted treatment to pregnant inmates. The law applies only to women who are pregnant and incarcerated, and it allows a competent woman to decline the treatment if she wishes.

Key Provisions

The Bureau of Prisons must offer medication‑assisted treatment (MAT) for opioid addiction to every pregnant woman it holds in custody.
If a pregnant woman is deemed mentally competent, she may choose to refuse the MAT.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action

HouseIntro Referral Latest Action

Referred to the House Committee on the Judiciary.

Judiciary Committee

July 16, 2026

View full timeline

HouseIntro Referral

Introduced in House

July 16, 2026

HouseIntro Referral

Referred to the House Committee on the Judiciary.

Judiciary Committee

July 16, 2026

Bill Text

Latest available legislative text

Reading Mode

Raw Text PDF XML

Introduced in HouseIssued July 16, 2026

119th CONGRESS

2d Session

H. R. 9756

IN THE HOUSE OF REPRESENTATIVES

July 16, 2026

Mr. McGuire introduced the following bill; which was referred to the Committee on the Judiciary

A BILL

To direct the Director of the Bureau of Prisons to provide medication assisted treatment for opioid addiction to certain women.

Short title

This Act may be cited as the Maternal Access to Treatment Act of 2026 or the MAT Act of 2026.

Medication assisted treatment

(a)

Requirement

The Director of the Bureau of Prisons shall provide medication assisted treatment (commonly known as MAT) to each pregnant woman in the custody of the Bureau of Prisons addicted to opioids.

(b)

Exception

A pregnant woman who is mentally competent may deny the provision of medication assisted treatment under subsection (a).